PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains

Human Molecular Genetics

Volumn 11, Issue 21, 2002, Pages 2547-2558

  Modregger, Jan ^a   DiProspero, Nicholas A ^b,c   Charles, Vinod ^b,e   Tagle, Danilo A ^b,d   Plomann, Markus ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e Psychiatric Genomics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; GLUTATHIONE TRANSFERASE; HUNTINGTIN; HYBRID PROTEIN; ISOPROTEIN; PHOSPHOPROTEIN; POLYGLUTAMINE; PROTEIN PACSIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL DEGENERATION; NEURITE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SYNAPSE VESICLE; TISSUE DISTRIBUTION; TRINUCLEOTIDE REPEAT;

ANIMALIA;

EID: 0036796261     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.21.2547     Document Type: Article

References (44)

1. DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S.A., Boyce, F.M. and Aronin, N. (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron, 14, 1075-1081.
2. Gutekunst, C.-A., Levey, A.I., Heilman, C.J., Whaley, W.L., Yi, H., Nash, N.R., Rees, H.D., Madden, J.J. and Hersch, S.M. (1995) Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl Acad. Sci. USA, 92, 8710-8714.
3. Trottier, Y., Lutz, Y., Stevanin, G., Imbert, G., Devys, D., Cancel, G., Saudou, F., Weber, C., David, G., Tora, L. et al. (1995) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature, 378, 403-406.
4. De Rooij, K.E., Dorsman, J.C., Smoor, M.A., Den Dunnen, J.T. and Van Ommen, G.J. (1996) Subcellular localization of the Huntington's disease gene product in cell lines by immnofluorescence and biochemical subcellular fractionation. Hum. Mol. Genet., 5, 1093-1099.
5. Persichetti, F., Carlee, L., Faber, P.W., McNeil, S.M., Ambrose, C.M., Srinidhi, J., Anderson, M., Barnes, G.T., Gusella, J.F and MacDonald, M.E. (1996) Differential expression of normal and mutant Huntington's disease gene alleles. Neurobiol. Dis., 3, 183-190.
6. Leavitt, BR., Wellington, C.L. and Hayden, M.R. (1999) Recent insights into the molecular pathogenesis of Huntington disease. Semin. Neurol., 19, 385-395.
7. Saudou, E, Finkbeiner, S., Devys, D. and Greenberg, M.E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell, 95, 55-66.
8. Yamamoto, A., Lucas, J.J. and Hen, R. (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell, 101, 57-66.
9. Davies, S.W., Turmaine, M., Cozens, B.A., DiFiglia, M., Sharp, A.H., Ross, C.A., Scherzinger, E., Wanker, E.E., Mangiarini, L. and Bates, G.P. (1997) Formation of intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell, 90, 537-548.
10. Reddy, P.H., Williams, M., Charles, V, Garrett, L., Pike-Buchanan, L., Whetsell, W.O., Miller, G. and Tagle, D.A. (1998) Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat. Genet., 20, 198-202.
11. Burke, J.R., Enghild, J.J., Martin, M.E., Jou, Y.S., Myers, R.M., Roses, A.D., Vance, J.M. and Strittmatter, W.J. (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat. Med., 2, 347-350.
12. Li, X.J., Li, S.H., Sharp, A.H., Nucifora, F.C.J., Schilling, G., Lanahan, A., Worley, R, Snyder, S.H. and Ross, C.A. (1995) A huntingtin-associated protein enriched in brain with implication for pathology. Nature, 378, 398-402.
13. Sittler, A., Walter, S., Wedemeyer, N., Hasenbank, R., Scherzinger, E., Eickhoff, H., Bates, G.P., Lehrach, H. and Wanker, E.E. (1998) SH3GL3 associates with huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. Mol. Cell, 2, 427-436.
14. Wanker, E.E., Rovira, C., Scherzinger, E., Hasenbank, R., Walter, S., Tait, D., Colicelli, J. and Lehrach, H. (1997) HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet., 6, 487-495.
15. Usdin, M.T., Shelbourne, P.F, Myers, R.M. and Madison, D.V. (1999) Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum. Mol. Genet., 8, 839-846.
16. Nicniocaill, B., Haraldsson, B., Hansson, O., O'Connor, W.T. and Brundin, P. (2001) Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice. Eur. J. Neurosci., 13, 206-210.
17. Dewhurst, K., Oliver, J., Trick, K.L. and McKnight, A.L. (1969) Neuropsychiatric aspects of Huntington's disease. Confin. Neurol., 31, 258-268.
18. Folstein, S.E. and Folstein, M.F. (1983) Psychiatric features of Huntington's disease: recent approaches and findings. Psychiatr. Dev., 1, 193-205.
19. Lawrence, A.D., Sahakian, B.J., Hodges, J.R., Rosser, A.E., Lange, K.W. and Robbins, T.W. (1996) Executive and mnemonic functions in early Huntington's disease. Brain, 119, 1633-1645.
20. Jason, G.W, Suchowersky, O., Pajurkova, E.M., Graham, L., Klimek, M.L., Garber, A.T. and Poirier-Heine, D. (1997) Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. Arch. Neural., 54, 1081-1088.
21. Lawrence, A.D., Weeks, R.A., Brooks, D.J., Andrews, T.C., Watkins, L.H., Harding, A.E., Robbins, T.W. and Sahakian, B.J. (1998) The relationship between striatal. dopamine receptor binding and cognitive performance in Huntington's disease. Brain, 121, 1343-1355.
22. Berrios, G.E., Wagle, A.C., Markova, I.S., Wagle, S.A., Ho, L.W., Rubinsztein, D.C., Whittaker, J., French-Constant, C., Kershaw, A., Rosser, A. et al. (2001) Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers. Psychiatry Res., 102, 217-225.
23. Beal, M.F., Kowall, N.W, Ellison, D.W, Mazurek, M.F., Swartz, K.J. and Martin, J.B. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature, 321, 168-171.
24. Qualmann, B., Roos, J., DiGregorio, P.J. and Kelly, R.B. (1999) Syndapin I, a synaptic dynamin-binding protein that associates with the neural Wiskott-Aldrich syndrome protein. Mol. Biol. Cell, 10, 501-513.
25. Modregger, J., Ritter, B., Witter, B., Paulsson, M. and Plomann, M. (2000) All three PACSIN isoforms bind to endocytic proteins and inhibit endocytosis. J. Cell Sci., 113, 4511-4521.
26. Wasiak, S., Quinn, C.C., Ritter, B., de Heuvel, E., Baranes, D., Plomann, M. and McPherson, P.S. (2001) The Ras/Rac guanine nucleotide exchange factor mammalian son-of-sevenless interacts with PACSIN 1/syndapin I, a regulator of endocytosis and the actin cytoskeleton. J. Biol. Chem., 276, 26622-26628.
27. Qualmann, B. and Kelly, R.B. (2000) Syndapin isoforms participate in receptor-mediated endocytosis and actin organisation. J. Cell Biol., 148, 1047-1061.
28. Perutz, M.F. (1996) Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. Curr. Opin. Struct. Biol., 6, 848-858.
29. Kalchman, M.A., Koide H.B., McCutcheon K., Graham R.K., Nichol K., Nishiyama K., Kazemi-Esfarjani P., Lynn F.C., Wellington C., Metzler M. et al. (1997) HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat. Genet., 16, 44-53.
30. Metzler, M., Legendre-Guillemin, V, Gan, L., Chopra, V, Kwok, A., McPherson, P.S. and Hayden, M.R. (2001) HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2. J. Biol. Chem., 276, 39271-39276.
31. Mishra, S.K., Agostinelli, N.R., Brett, T.J., Mizukami, I., Ross, T.S. and Traub, L.M. (2001) Clathrin- and AP-2-binding sites in HIP1 uncover a general assembly role for endocytic accessory proteins. J. Biol. Chem., 276, 46230-46236.
32. Waelter, S., Scherzinger, E., Hasenbank, R., Nordhoff, E., Lurz, R., Goehler, H., Gauss, C., Sathasivam, K., Bates, G.P., Lehrach, H. and Wanker, E.E. (2001) The huntingtin interacting protein HIP1 is a clathrin and α-adaptin-binding protein involved in receptor-mediated endocytosis. Hum. Mol. Genet., 10, 1807-1817.
33. Ringstad, N., Gad, H., Löw, P., Di Paolo, G., Brodin, L., Shupliakov, O. and De Camilli, P. (1999) Endophilin/SH3p4 is required for the transition from early to late stages in clathrin-mediated synaptic vesicle endocytosis. Neuron, 24, 143-154.
34. Simpson, F., Hussain N.K., Qualmann B., Kelly R.B., Kay B.K., McPherson P.S. and Schmid S.L. (1999) SH3-domain-containing proteins function at distinct steps in clathrin-coated vesicle formation. Nat. Cell Biol., 1, 119-124.
35. Gad, H., Ringstad N., Low R, Kjaerulff O., Gustafsson J., Wenk M., Di Paolo G., Nemoto Y., Crun J., Ellisman M.H. et al. (2000) Fission and uncoating of synaptic clathrin-coated vesicles are perturbed by disruption of interactions with the SH3 domain of endophilin. Neuron, 27, 301-312.
36. Wood, J.D., MacMillan, J.C., Harper, P.S., Lowenstein, P.R. and Jones, A.L. (1996) Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain. Hum. Mol. Genet., 5, 481-487.
37. Velier, J., Kim, M., Schwarz, C., Kim, T.W, Sapp, E., Chase, K., Aronin, N. and DiFiglia, M.. 1998. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp. Neurol., 152, 34-40.
38. McNiven, M.A., Cao, H., Pitts, K.R. and Yoon, Y. (2000) The dynamin family of mechanoenzymes: pinching in new places. Trends Biochem. Sci., 25, 115-120.
39. Martin-Aparicio, E., Yamamoto, A., Hernandez, F., Hen, R., Avila, J. and Lucas, J.J. (2001) Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease. J. Neurosci., 21, 8772-8781.
40. Parker, J.A., Connolly, J.B., Wellington, C., Hayden, M., Dausset, J. and Neri, C. (2001) Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc. Natl Acad. Sci. USA, 98, 13318-13323.
41. Plomann, M., Lange, R., Vopper, G., Cremer, H., Heinlein, U.A.O., Scheff, S., Baldwin, S.A., Leitges, M., Cramer, M., Paulsson, M. and Barthels, D. (1998) PACSIN, a brain protein that is upregulated upon differentiation into neuronal cells. Eur. J. Biochem., 256, 201-211.
42. Gray, E.G. and Whittaker, V.P. (1962) The isolation of nerve endings from brain: an electron microcopic study of cell fragments derived by homogenization and centrifugation. J. Anat., 96, 79-86.
43. Jiao, Y., Sun, Z., Lee, T., Fusco, F.R., Kimble, T.D., Meade, C.A., Cuthbertson, S. and Reiner, A. (1999) A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections. J. Neurosci. Meth., 93, 149-162.
44. Schnell, S.A., Staines, W.A. and Wessendorf, M.W. (1999) Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J. Histochem. Cytochem., 47, 719-730.